Page last updated: 2024-11-02

pantoprazole and Nephrocalcinosis

pantoprazole has been researched along with Nephrocalcinosis in 1 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Nephrocalcinosis: A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference
" Long-term use is the main factor, but there are a few articles stating that it may also emerge with short-term use."1.48Short-Term Effect of High-Dose Pantoprazol on Serum and Urinary Magnesium Levels. ( Bostan, F; Cekin, AH; Dolu, S; Ellidag, HY; Kok, M; Sahinturk, Y; Uyar, S; Yolcular, BO, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uyar, S1
Dolu, S1
Yolcular, BO1
Ellidag, HY1
Kok, M1
Bostan, F1
Sahinturk, Y1
Cekin, AH1

Other Studies

1 other study available for pantoprazole and Nephrocalcinosis

ArticleYear
Short-Term Effect of High-Dose Pantoprazol on Serum and Urinary Magnesium Levels.
    Clinical laboratory, 2018, Mar-01, Volume: 64, Issue:3

    Topics: Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Hospitalization; Humans; Hype

2018